Christine Hicking

3PUBLICATIONS
19CO-AUTHORS
Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 28, 2025
A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors.

Lillian L Siu, Timothy A Yap, Sofia Genta

|Aug 21, 2025
Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib.

Jatinder Kaur Mukker, Paul Matthias Diderichsen, Farina Hellmann

|Feb 26, 2024
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.

Timothy A Yap, Anthony W Tolcher, Ruth Plummer

Pageof 1